bili-hut is a high-intensity phototherapy device for treating jaundiced baby. This infant phototherapy device is portable, power-adaptable for treating neonatal jaundice - anywhere in the world.
Location: United States, Massachusetts, Somerville
Employees: 11-50
Total raised: $3M
Investors 2
| Date | Name | Website |
| - | FHI Ventur... | fhiventure... |
| - | MassChalle... | masschalle... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 09.05.2024 | Seed | $3M | - |
Mentions in press and media 5
| Date | Title | Description |
| 09.05.2024 | Little Sparrows Technologies Raises $3M In Seed Funding | Little Sparrows Technologies, a Woburn, MA-based neonatal medical device startup, raised $3M in Seed funding. The backers were not disclosed. The company intends to use the funds to expand operations and development efforts. Founded in 2013... |
| 14.12.2020 | Little Sparrows Technologies bili•hut™ Phototherapy Trial Lights the Way for Outpatient Treatment of Infant Jaundice | bili•hut™ neonatal phototherapy system Our practice is very impressed by how effective bili•hut is compared to biliblanket phototherapy in treating jaundice. It is easy to administer, shortens the time required for phototherapy and keeps in... |
| 10.09.2015 | MassChallenge Touts Gender Diversity Stats As Wider Dialogue Builds | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Lalita Booth is the CEO of a six-person startup, Navitome, which includes two women and four men. But such is the state of the tech industry that sometimes when she walks into... |
| 16.01.2014 | 14 health care innovation predictions for 2014 | By Vector Staff 2013 saw an accelerated crumbling of borders and boundaries in health care, fueled by technological and scientific advances. Boundaries between high-tech Western medicine and global health practices have begun blurring in in... |
| - | Little Sparrows Technologies | “bili-hut is a high-intensity phototherapy device for treating jaundiced baby. This infant phototherapy device is portable, power-adaptable for treating neonatal jaundice - anywhere in the world.” |